REQUEST A DEMO
Total
USD $0.00
Search more companies

Laboratorio Pharmazen S.A.S (Colombia)

Main Activities: All Other Miscellaneous Food Manufacturing
Full name: Laboratorio Pharmazen S.A.S Profile Updated: April 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Laboratorio Pharmazen S.A.S is based in Colombia, with the head office in Bogota D.C.. The company operates in the All Other Miscellaneous Food Manufacturing industry. Laboratorio Pharmazen S.A.S was incorporated on December 14, 2020. There are currently 20 (2025) people employed by Laboratorio Pharmazen S.A.S. In 2024, the company reported a net sales revenue increase of 27.06%. The net profit margin of Laboratorio Pharmazen S.A.S increased by 0.59% in 2024.

Headquarters
Carrera 96 # 66A - 53
Bogota D.C.; Bogota D.C; Postal Code: 0918

Contact Details: Purchase the Laboratorio Pharmazen S.A.S report to view the information.

Basic Information
Total Employees:
Purchase the Laboratorio Pharmazen S.A.S report to view the information.
Financial Auditors:
Purchase the Laboratorio Pharmazen S.A.S report to view the information.
Incorporation Date:
December 14, 2020
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Laboratorio Pharmazen S.A.S report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
27.06%
Total operating revenue
27.06%
Operating profit (EBIT)
59.96%
Net Profit (Loss) for the Period
59.96%
Total Assets
0%
Total Equity
0%
Operating Profit Margin (ROS)
0.59%
Net Profit Margin
0.59%
Return on Equity (ROE)
156.69%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?